Savant Capital LLC Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Savant Capital LLC bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, HoldingsChannel.com reports. The firm bought 3,492 shares of the company’s stock, valued at approximately $264,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Everett Harris & Co. CA grew its position in shares of Henry Schein by 29.1% during the 4th quarter. Everett Harris & Co. CA now owns 104,677 shares of the company’s stock valued at $7,925,000 after acquiring an additional 23,622 shares during the period. Duality Advisers LP purchased a new position in shares of Henry Schein during the 4th quarter valued at approximately $1,561,000. Sprucegrove Investment Management Ltd. increased its holdings in Henry Schein by 14.2% in the 4th quarter. Sprucegrove Investment Management Ltd. now owns 220,491 shares of the company’s stock worth $16,693,000 after acquiring an additional 27,500 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Henry Schein by 215.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 74,251 shares of the company’s stock valued at $5,622,000 after purchasing an additional 50,723 shares in the last quarter. Finally, Caxton Associates LP increased its stake in shares of Henry Schein by 80.8% during the third quarter. Caxton Associates LP now owns 18,991 shares of the company’s stock worth $1,410,000 after purchasing an additional 8,486 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at approximately $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on HSIC. Piper Sandler boosted their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. Jefferies Financial Group increased their price objective on Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. Barrington Research lifted their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Finally, SVB Leerink started coverage on shares of Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $81.09.

Henry Schein Trading Up 1.1 %

Shares of Henry Schein stock opened at $68.53 on Tuesday. Henry Schein, Inc. has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67. The firm has a market capitalization of $8.80 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 1.68 and a beta of 0.87. The stock has a 50 day moving average of $73.22 and a 200 day moving average of $72.32.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. During the same period in the previous year, the business posted $1.21 earnings per share. The firm’s revenue for the quarter was down 10.5% compared to the same quarter last year. As a group, research analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.